Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
12:07:28 EDT Sat 04 May 2024
Enter Symbol
or Name
USA
CA



News for U:GMDA from 2023-05-04 to 2024-05-03 - 28 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-08 07:30U:GMDANews ReleaseXORTX Welcomes New Member to the Board of Directors
2024-04-01 08:00U:GMDANews ReleaseAquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
2024-03-27 07:00U:GMDANews ReleaseGamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital Management
2024-03-27 07:00U:GMDANews ReleaseGamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update
2024-03-22 08:00U:GMDANews ReleaseGamida Cell to Report Fourth Quarter and Full-Year 2023 Financial Results
2024-02-23 08:00U:GMDANews ReleaseGamida Cell Data Presented at the 2024 Tandem Meetings of ASTCT(TM) and CIBMTR(TM)
2024-01-29 06:00U:GMDANews ReleaseGamida Cell Actively Pursuing Strategic Alternatives
2024-01-17 08:00U:GMDANews ReleaseGamida Cell to Present at the 2024 Tandem Meetings of ASTCT ‚ ® and CIBMTR ‚ ®
2023-11-27 20:12U:GMDANews ReleaseGamida Cell to Host Virtual Thought Leader Fireside Chat on December 4, 2023
2023-11-20 08:00U:GMDANews ReleaseGamida Cell to Present Corporate Highlights at the Piper Sandler 35th Annual Healthcare Conference
2023-11-14 07:00U:GMDANews ReleaseGamida Cell Reports Third Quarter 2023 Financial Results and Provides Company Update
2023-11-04 08:00U:GMDANews ReleaseGamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual Meeting
2023-11-01 08:00U:GMDANews ReleaseGamida Cell to Report Third Quarter 2023 Financial Results
2023-10-16 16:39U:GMDANews ReleaseGamida Cell Reports Preliminary Data from Phase 1 Study of Natural Killer (NK) Cell Therapy Candidate GDA-201
2023-10-09 14:00U:GMDANews ReleaseGamida Cell Issues Update on Israel Operations
2023-10-02 08:00U:GMDANews ReleaseGamida Cell to Present Corporate Highlights at 2023 Cell & Gene Meeting on the Mesa
2023-09-28 08:00U:GMDANews ReleaseGamida Cell to Present at Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting
2023-09-27 16:30U:GMDANews ReleaseFirst Patient Receives Gamida Cell's Omisirge ¢ „ ¢ (omidubicel-onlv)
2023-08-31 08:00U:GMDANews ReleaseGamida Cell to Present Corporate Highlights at the H.C. Wainwright 25th Annual Global Investment Conference
2023-08-14 07:00U:GMDANews ReleaseGamida Cell Reports Second Quarter and First Half 2023 Financial Results and Provides Company Update
2023-08-01 08:00U:GMDANews ReleaseGamida Cell to Report Second Quarter 2023 Financial Results
2023-07-11 08:00U:GMDANews ReleaseData Published in Transplantation and Cellular Therapy Suggest Antiviral Protection After Transplantation with Gamida Cell ¢ € ™s Omisirge ‚ ® (omidubicel-onlv)
2023-07-10 14:00U:GMDANews ReleaseSTAND UP TO CANCER NAMES JULIAN ADAMS, Ph.D., CHIEF SCIENCE OFFICER
2023-06-14 16:30U:GMDANews ReleaseGamida Cell To Host Investor Day
2023-05-31 16:30U:GMDANews ReleaseGamida Cell to Present Corporate Highlights at the Jefferies Healthcare Conference
2023-05-31 07:00U:GMDANews ReleaseData To Be Presented on Gamida Cell Natural Killer (NK) Cell Therapy Candidate GDA-201 at the International Society for Cell & Gene Therapy 2023 Annual Meeting
2023-05-15 16:05U:GMDANews ReleaseGamida Cell Reports First Quarter 2023 Financial Results and Provides Company Update
2023-05-11 17:20U:GMDANews ReleaseGamida Cell Announces the Date of Its First Quarter 2023 Financial Results and Webcast